{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:02:01Z","timestamp":1762077721745,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004340","name":"Siemens USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ahj.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T01:48:27Z","timestamp":1562982507000},"page":"82-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale"],"prefix":"10.1016","volume":"216","author":[{"given":"Laura","family":"Mauri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gheorghe","family":"Doros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil V.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Yakubov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lasala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Chiu","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Zidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean J.","family":"Kereiakes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ahj.2019.07.003_bb0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/01.CIR.83.1.148","article-title":"Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study","volume":"83","author":"Schatz","year":"1991","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahj.2019.07.003_bb0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0195-668X(02)00802-3","article-title":"Direct stenting","volume":"24","author":"Barbato","year":"2003","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.ahj.2019.07.003_bb0015","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1001\/jama.297.18.1992","article-title":"Outcomes and complications associated with off-label and untested use of drug-eluting stents","volume":"297","author":"Beohar","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ahj.2019.07.003_bb0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcin.2008.01.003","article-title":"Direct stenting with the TAXUS Liberte drug-eluting stent: results from the Taxus Atlas Direct Stent Study","volume":"1","author":"Ormiston","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.ahj.2019.07.003_bb0025","first-page":"245","article-title":"Direct coronary stenting without predilatation: a new therapeutic approach with a special balloon catheter design","volume":"43","author":"Figulla","year":"1998","journal-title":"Cathet Cardiovasc Diagn"},{"issue":"1 Pt 1","key":"10.1016\/j.ahj.2019.07.003_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-8703(99)70246-2","article-title":"Direct coronary stenting without balloon predilation in acute coronary syndromes","volume":"138","author":"Hamon","year":"1999","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.ahj.2019.07.003_bb0035","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0002-9149(98)00683-3","article-title":"Direct stent implantation without predilatation using the MultiLink stent","volume":"82","author":"Pentousis","year":"1998","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2019.07.003_bb0040","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0735-1097(99)00639-7","article-title":"Immediate and late outcomes after direct stent implantation without balloon predilation","volume":"35","author":"Wilson","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2019.07.003_bb0045","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/S0735-1097(99)00453-2","article-title":"Direct coronary stenting without predilation","volume":"34","author":"Briguori","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ahj.2019.07.003_bb0050","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0002-9149(99)00540-8","article-title":"Stent implantation without predilation in patients with a single, noncalcified coronary artery lesion","volume":"84","author":"Danzi","year":"1999","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2019.07.003_bb0055","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0002-9149(99)00926-1","article-title":"Evaluation of direct stent implantation without predilatation by intravascular ultrasound","volume":"85","author":"de la Torre Hernandez","year":"2000","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2019.07.003_bb0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0195-668X(02)00701-7","article-title":"Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: six month results of a randomized trial","volume":"24","author":"IJsselmuiden","year":"2003","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2019.07.003_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14628840304607","article-title":"Hout Bv, et\u00a0al. Direct stenting with the Bx VELOCITY balloon-expandable stent mounted on the Raptor rapid exchange delivery system versus predilatation in a European randomized Trial: the VELVET trial","volume":"5","author":"Serruys","year":"2003","journal-title":"Int J Cardiovasc Intervent"},{"issue":"11","key":"10.1016\/j.ahj.2019.07.003_bb0070","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0002-9149(02)02832-1","article-title":"Direct coronary stenting versus predilatation followed by stent placement","volume":"90","author":"Brueck","year":"2002","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2019.07.003_bb0075","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/euhj.2001.2893","article-title":"Direct coronary stenting versus stenting with balloon pre-dilation: immediate and follow-up results of a multicentre, prospective, randomized study. The DISCO trial. DIrect Stenting of COronary Arteries","volume":"23","author":"Martinez-Elbal","year":"2002","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ahj.2019.07.003_bb0080","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0002-9149(03)00009-2","article-title":"Comparison of outcomes (early and six- month) of direct stenting with conventional stenting (a meta-analysis of ten randomized trials)","volume":"91","author":"Burzotta","year":"2003","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ahj.2019.07.003_bb0085","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0002-9149(01)02114-2","article-title":"Comparison of PRE-dilatation vs direct stenting in coronary treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial)","volume":"88","author":"Baim","year":"2001","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.07.003_bb0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.amjcard.2005.08.041","article-title":"Effectiveness of \"direct\" stenting without balloon predilatation (from the Multilink Tetra Randomised European Direct Stent Study [TRENDS])","volume":"97","author":"Dawkins","year":"2006","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2019.07.003_bb0095","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-9149(00)01485-5","article-title":"Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris. BET (Benefit Evaluation of Direct Coronary Stenting) Study Group","volume":"87","author":"Carrie","year":"2001","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.07.003_bb0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-8703(03)00259-X","article-title":"Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry","volume":"146","author":"Cohen","year":"2003","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.ahj.2019.07.003_bb0105","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.amjcard.2006.06.026","article-title":"Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry)","volume":"98","author":"Feldman","year":"2006","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.07.003_bb0110","first-page":"335","article-title":"Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention","volume":"67","author":"McCullough","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.ahj.2019.07.003_bb0115","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.amjcard.2003.07.023","article-title":"Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention","volume":"92","author":"Naidu","year":"2003","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2019.07.003_bb0120","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0735-1097(02)01731-X","article-title":"Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000","volume":"39","author":"Shaw","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.07.003_bb0125","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jacc.2005.09.071","article-title":"A\u00a0risk score to predict in-hospital mortality for percutaneous coronary interventions","volume":"47","author":"Wu","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2019.07.003_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0002-9149(94)90199-6","article-title":"Comparison of fixed-wire and over-the-wire balloon dilatation systems for percutaneous transluminal coronary angioplasty","volume":"73","author":"O'Neill","year":"1994","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.07.003_bb0135","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0735-1097(88)80059-7","article-title":"Efficacy of a new angioplasty catheter for severely narrowed coronary lesions","volume":"12","author":"Thomas","year":"1988","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ahj.2019.07.003_bb0140","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.105.601823","article-title":"Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents","volume":"113","author":"Kastrati","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ahj.2019.07.003_bb0145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa051175","article-title":"Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization","volume":"353","author":"Windecker","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ahj.2019.07.003_bb0150","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMoa044372","article-title":"Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients","volume":"353","author":"Dibra","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ahj.2019.07.003_bb0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.293.2.165","article-title":"Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial","volume":"293","author":"Kastrati","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ahj.2019.07.003_bb0160","first-page":"589","article-title":"Comparison of the effectiveness of sirolimus- and paclitaxel-eluting stents for small coronary artery lesions","volume":"67","author":"Park","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.ahj.2019.07.003_bb0165","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacc.2005.09.047","article-title":"Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different","volume":"47","author":"Wessely","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2019.07.003_bb0170","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jacc.2006.05.068","article-title":"Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents","volume":"48","author":"Elezi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2019.07.003_bb0175","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2006.07.013","article-title":"All drug-eluting stents are equal, but some drug-eluting stents are more equal than others","volume":"48","author":"Strauss","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2019.07.003_bb0180","first-page":"94","article-title":"Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries","volume":"69","author":"Tanimoto","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.ahj.2019.07.003_bb0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/eurheartj\/ehi721","article-title":"Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels","volume":"27","author":"Mehilli","year":"2006","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2019.07.003_bb0190","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2006.09.042","article-title":"Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study","volume":"49","author":"Petronio","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2019.07.003_bb0195","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jacc.2006.03.063","article-title":"Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry","volume":"48","author":"Saia","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2019.07.003_bb0200","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.108.803528","volume":"119","author":"Stone","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2019.07.003_bb0205","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacc.2005.10.045","article-title":"The Stenting Coronary Arteries in Non-stress\/benestent Disease (SCANDSTENT) trial","volume":"47","author":"Kelbaek","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2019.07.003_bb0210","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa0706258","article-title":"A\u00a0comparison of bare-metal and drug-eluting stents for off-label indications","volume":"358","author":"Marroquin","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ahj.2019.07.003_bb0215","first-page":"31","article-title":"New drug-eluting stents with biodegradable polymers","volume":"59","author":"Van Der Giessen","year":"2011","journal-title":"Minerva Cardioangiol"},{"issue":"10 Suppl","key":"10.1016\/j.ahj.2019.07.003_bb0220","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2010.06.008","article-title":"Coronary stents: looking forward","volume":"56","author":"Garg","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.ahj.2019.07.003_bb0225","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/eurheartj\/ehp352","article-title":"Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial","volume":"30","author":"Byrne","year":"2009","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ahj.2019.07.003_bb0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00019501-200206000-00006","article-title":"In-vivo biocompatibility evaluation of stents coated with a new biodegradable elastomeric and functional polymer","volume":"13","author":"Lee","year":"2002","journal-title":"Coron Artery Dis"},{"issue":"11","key":"10.1016\/j.ahj.2019.07.003_bb0235","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1163\/092050609X12464344572881","article-title":"Poly(ester amide) co-polymers promote blood and tissue compatibility","volume":"20","author":"DeFife","year":"2009","journal-title":"J\u00a0Biomater Sci Polym Ed"},{"issue":"2","key":"10.1016\/j.ahj.2019.07.003_bb0240","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jbm.a.32858","article-title":"Biological performance of biodegradable amino acid-based poly(ester amide)s: Endothelial cell adhesion and inflammation in vitro","volume":"95","author":"Horwitz","year":"2010","journal-title":"J\u00a0Biomed Mater Res A"},{"issue":"17","key":"10.1016\/j.ahj.2019.07.003_bb0245","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2019.07.003_bb0250","doi-asserted-by":"crossref","unstructured":"Kereiakes DJ, Meredith IT, Windecker S, et\u00a0al . Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial. Circ Cardiovasc Interv 2015;8(4); pii: e002372. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.114.002372.","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372"},{"issue":"15","key":"10.1016\/j.ahj.2019.07.003_bb0255","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2011.12.016","article-title":"Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent","volume":"59","author":"Meredith","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.ahj.2019.07.003_bb0260","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/CIRCULATIONAHA.117.028885","article-title":"Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis)","volume":"136","author":"Kandzari","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2019.07.003_bb0265","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcin.2016.11.049","article-title":"Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States","volume":"10","author":"Amin","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.ahj.2019.07.003_bb0270","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/M15-1277","article-title":"Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis","volume":"163","author":"Ando","year":"2015","journal-title":"Ann Intern Med"},{"issue":"22","key":"10.1016\/j.ahj.2019.07.003_bb0275","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.jcin.2017.08.047","article-title":"25 Years of Transradial Intervention: Looking Back and Anticipating What Is Ahead","volume":"10","author":"Rao","year":"2017","journal-title":"JACC Cardiovasc Interv"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319301784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319301784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:57:17Z","timestamp":1762077437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319301784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":55,"alternative-id":["S0002870319301784"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.07.003","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}